News | ECG | August 10, 2015

ECG Screening May Predict Heart Disease Mortality for Kidney Disease Patients

Routine scans could help clinicians protect patients’ heart health

ECG screening, risk of dying, heart disease, chronic kidney disease, CKD, Rajat Deo, Perelman School of Medicine

August 10, 2015 — Several common measures obtained from electrocardiograms (ECGs) may help clinicians determine a kidney disease patient’s risk of dying from heart disease. The findings, which are published in a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN), may be important for preserving kidney patients’ heart health.

ECG screening is not recommended for routinely assessing heart health in low-risk populations such as young athletes; however, would ECGs be useful in a higher-risk population such as those with chronic kidney disease (CKD), whose leading cause of death is heart disease?

To investigate, Rajat Deo, M.D., MTR, Perelman School of Medicine at the University of Pennsylvania, and his colleagues evaluated whether a panel of five common ECG parameters could enhance prediction of CKD patients’ risk of dying over a median follow-up of 7.5 years.

Among 3,587 patients in the study, 750 participants died. The researchers found that common ECG measures (PR interval, QRS duration, corrected QT interval, heart rate and left ventricular hypertrophy) identified individuals with CKD who were at an especially high risk of dying from heart disease. “By enhancing the prediction of cardiovascular death in this population, we may find more effective and novel interventions to prevent the complications of cardiovascular disease,” said Deo.

Additional research is needed to evaluate whether treating patients who are found to be at especially high risk due to ECG screening will help to improve and prolong the lives of individuals with CKD.

For more information: www.jasn.asnjournals.org


Related Content

News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
News | ECG

Jan. 8, 2026 — AccurKardia recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the ...

Home January 15, 2026
Home
News | ECG

Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...

Home January 14, 2026
Home
News | ECG

Oct. 8, 2025 — Viz.ai recently launched Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute ...

Home October 09, 2025
Home
News | ECG

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...

Home August 15, 2025
Home
News | ECG

July 24, 2025 — Royal Philips has announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory ...

Home July 24, 2025
Home
Subscribe Now